Search results
- 16.74Add to watchlist-0.13 (-0.77%)At close:4:00 PM EDTThu. Sep 5, 202416.74 0.00 (0.00%)After hrs:7:47 PM EDTThu. Sep 5, 2024Nasdaq Real Time Price (USD) · Market closed
- Open16.79High16.79Low16.32
- Mkt Cap3.93BP/E (TTM)119.57Div & YieldN/A & N/A
- Prev. Close16.8752 Wk. Low3.0652 Wk. High18.48
Related stocks
Aug 14, 2024 · ADMA Biologics is an end-to-end commercial biopharmaceutical company committed to manufacturing, marketing, and developing specialty plasma-derived products for the prevention and treatment of infectious diseases in the immune compromised and other patients at risk for infection.
- Press Releases
ADMA Biologics Announces Fourth Quarter and Full Year 2023...
- Email Alerts
To opt-in for investor email alerts, please select at least...
- Financial Results
Financial Results - Investor Relations :: ADMA Biologics,...
- Balance Sheet
Balance Sheet - Investor Relations :: ADMA Biologics, Inc.
- Income Statement
Income Statement - Investor Relations :: ADMA Biologics,...
- Cash Flow
Cash Flow - Investor Relations :: ADMA Biologics, Inc.
- Annual Reports
FISCAL YEAR ENDED DEC 31, 2022. Earnings Release 116.1 KB....
- SEC Filings
0001140361-24-038772.xls. Aug 26, 2024. Filed by "insiders"...
- Stock Data & Quote
Recent Price $17.35: Recent Price 8/27/24: 52 Week High...
- ADMA Biologics 2Q 2024 Earnings Call
ADMA Biologics 2Q 2024 Earnings Call - Investor Relations ::...
- Press Releases
6 days ago · Discover real-time ADMA Biologics Inc Common Stock (ADMA) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
2 days ago · ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
- 4.08B
- 330.24M
- 34.79M
- 233.08M
Aug 30, 2024 · ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
Aug 13, 2024 · Adma Biologics (ADMA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Aug 30, 2024 · ADMA grew revenue by 78% on a year-over-year basis (to $107.2 million) and posted per-share earnings of $0.32. Profits jumped to $57.5 million, good for a gross margin of 53.6% versus 27.8% the ...
People also ask
Who is ADMA biologics?
Who owns ADMA Biologics Inc stock?
How will ADMA biologics perform in fiscal year?
How did ADMA biologics perform in 2023?
6 days ago · ADMA Biologics, Inc. is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases.